Skip to navigation Skip to main content

VOTRIENT® (pazopanib) for Renal Cell Carcinoma

Slideshow

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

This slideshow reviews drug information for VOTRIENT® (pazopanib) for renal cell carcinoma.

Table of Contents

Slide 3: Indication, Dosage, and Administration
Slide 6: Use in Specific Populations
Slide 8: Clinical Pharmacology
Slide 12: Warnings and Precautions
Slide 19: Clinical Safety and Efficacy
Slide 23: Drug Storage and Supply

Topics:

Drug Showcase Kidney Cancer Renal Cell Carcinoma
  • Loading...

    Continuing Medical Education (CME/CE) Courses

    Show More

Next hm-slideshow in Slides